Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT06131580 Active, not recruiting - Clinical trials for Endogenous Cushing Syndrome

Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome

ISS-CA-2023
Start date: October 24, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to continue the evaluation of long-term safety of osilodrostat in 7 Canadian patients who have already received osilodrostat treatment in a previous Global Recordati-sponsored roll-over study and who, based on investigators' judgement, will continue benefiting with its administration.

NCT ID: NCT06124326 Active, not recruiting - Clinical trials for Premenstrual Syndrome

A Single Group Study to Evaluate the Effects of a Supplement on Premenstrual Syndrome

Start date: August 31, 2023
Phase: N/A
Study type: Interventional

This is a virtual single-group study that will last three menstrual cycles (approximately 12 weeks). During the first menstrual cycle, participants will take the supplement as needed (pro re nata) when they feel symptoms of PMS, such as cramping or bloating. For the second and third menstrual cycles, Participants will take 2 capsules per day with water for 1 week, starting 4 days before their menstrual cycle and finishing on Day 3 of their cycle. Questionnaires will be completed at the following time points: - Baseline - Day 7 of their first cycle during the trial (After using the product PRN during their period) - 4 days before their second period during the trial (After using the product PRN for the previous month) - Day 3 of their second period during the trial (After using the product for 7 days straight) - Day 3 of their third period of the trial (After using the product for 7 days straight)

NCT ID: NCT06124300 Active, not recruiting - Clinical trials for Polycystic Ovary Syndrome

Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

This is a virtual single group study that will last 12 weeks. Participants will take 1 scoop of the female hormone balance supplement, and mix it with their drink of choice every morning. Questionnaires will be completed at baseline, 1 week, 2 weeks, 4 weeks, and 12 weeks

NCT ID: NCT06098326 Active, not recruiting - Clinical trials for Myelodysplastic Syndromes

CyFluATG in Lower Risk MDS

Start date: March 6, 2018
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of the conditioning regimen with cyclophosphamide, fludarabine, and antithymocyte globulin (CyFluATG) for allogeneic hematopoietic cell transplantation (HCT) in patients with lower risk myelodysplastic syndrome (MDS). The efficacy of the treatment will be measured in terms of engraftment and non-relapse mortality (NRM).

NCT ID: NCT06079762 Active, not recruiting - Aging Clinical Trials

AGE SELF CARE: Promoting Healthy Aging Through a Group Visit Program

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Aim 1: To assess the feasibility and acceptability of delivering AGE SELF CARE through virtual medical group visits by measuring recruitment rate, adherence, and participant satisfaction. Hypothesis 1: It will be feasible to recruit 12 older adults who are pre-frail. Hypothesis 2: At least 70% of participants will attend 6 of 8 group visit sessions. Hypothesis 3: At least 70% of participants will report satisfaction with the program. Aim 2: Determine the feasibility and burden of measuring frailty in this study by different instruments. Hypothesis 1: At least 70% of participants will complete portions of all frailty assessments. Hypothesis 2: Participants will not find testing to be burdensome and measures may be completed in 60 minutes or less. Hypothesis 3: Mean gait speed and frailty index will improve from baseline to post-intervention.

NCT ID: NCT06024642 Active, not recruiting - Clinical trials for Overactive Bladder Syndrome

Study of V117957 in Overactive Bladder Syndrome

Start date: June 30, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with overactive bladder syndrome, compared to placebo.

NCT ID: NCT05970445 Active, not recruiting - Hearing Loss Clinical Trials

Clinical Phenotypic Characteristics of SC26A4

Start date: May 15, 2023
Phase:
Study type: Observational

The presence or absence of SC26A4, whether combined with Mondini malformation, and patient age, are important factors affecting the degree of hearing loss in the Chinese population.

NCT ID: NCT05964322 Active, not recruiting - Pediatric ALL Clinical Trials

Cardiac Rehabilitation of Children and Adolescent With Long QT Syndrome

RYTHMO'FIT
Start date: February 2, 2022
Phase:
Study type: Observational

Children and adolescents with inherited cardiac arrhythmia su ch Long QT Syndrome (LQTS) have lower physical and quality of life than their healthy peers. A multi-component cardiac rehabilitation, including an exercise training program and education program, might counteract those effects. The goal of this pilot study is to evaluate the security, feasibility, and benefits of a cardiac rehabilitation program in children with LQTS aged between 6 to 18 years old. The main question[s] it aims to answer are: - Is center-based cardiac rehabilitation safe and feasible for children with LQTS? - Does a 12-week cardiac rehabilitation program improve physical fitness and quality of life?

NCT ID: NCT05961319 Active, not recruiting - Healthy Clinical Trials

Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults

Start date: September 20, 2023
Phase:
Study type: Observational

This project aims to address the impact of frailty on older adults, particularly its connection to cognitive impairments such as dementia. By identifying frailty in its early stages, interventions can be designed to slow down the progression of cognitive decline. To achieve this, the project plans to develop a reliable at-home monitoring system that can accurately track frailty in older adults with mild cognitive impairment or dementia. By utilizing cutting-edge technologies such as high-precision indoor positioning and home-installed sensors, referred to as zero-effort technologies (ZETs), the system will collect continuous sensor data, which will be analyzed to identify indicators of frailty.

NCT ID: NCT05915117 Active, not recruiting - Metabolic Syndrome Clinical Trials

Effects of Polyphenols of Pomegranate Fruit Peel Extract on Inflammation and Oxidative Stress in Metabolic Syndrome

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of polyphenols of pomegranate fruit peel extract compared to placebo on oxidative stress and inflammation in overweight and obese subjects with metabolic syndrome.